Jesper Wiklund

Chief Business Officer @Cinclus Pharma

Munich, DE

EMAILS

[email protected]

MOBILE NUMBERS

+91 *********19

Reveal Contact Details

Signup · Get unlimited contacts

WORK HISTORY

Nov 2023 — Present

Chief Business Officer @Cinclus Pharma

View department →

Stockholm, SE

Responsible for Financing and Strategy as well as Corporate and Business Development. Togeher with CEO successfully completed IPO on NASDAQ Stockholm in June, 2024 with total proceeds of more than SEK 700 m/~€70m.

EDUCATION

1987 — 1991

Saint Mary's College of California

BS, Biology

1997 — 1999

Harvard Business School

MBA

SKILLS

Drug DiscoveryManagement ConsultingLife SciencesVenture FinancingLicensingCommercializationDrug DevelopmentBiopharmaceuticalsStrategic PartnershipsDue DiligenceVenture CapitalOncologyMergers & AcquisitionsBusiness StrategyEntrepreneurshipStrategyClinical DevelopmentLifesciencesDeal StructuringBusiness DevelopmentBiotechnologyCorporate DevelopmentPharmaceutical IndustryMergersStart-UpsManagementInternational BusinessNegotiationTechnology Transfer

ABOUT JESPER WIKLUND

30 years life science experience as an Entrepreneur, investor, CEO, BD exec and Board Member in Europe and the US. Proven ability to source, structure and execute financing, licensing, JV and M&A deals. Completed transactions with value >$1B. Sole focus on Biopharma throughout carrer, with a particular focus on CNS/Neuroscience and Gastrointestinal therapeutics.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.